Iovance Biotherapeutics
IOVA
#3883
Rank
C$4.57 B
Marketcap
C$9.89
Share price
-5.61%
Change (1 day)
210.70%
Change (1 year)

EPS for Iovance Biotherapeutics (IOVA)

EPS in 2026 (TTM): C-$0.74

According to Iovance Biotherapeutics 's latest financial reports the company's current EPS (TTM) is C-$0.76. In 2025 the company made an earnings per share (EPS) of C-$1.61 an increase over its 2024 EPS that were of C-$1.86.

EPS history for Iovance Biotherapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.74-54.04%
2025C-$1.61-13.85%
2024C-$1.86
2022C-$3.5611.71%
2021C-$3.18
2019C-$2.2723.44%
2018C-$1.84-9.22%
2017C-$2.02-20.34%
2016C-$2.54176.56%
2015C-$0.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
C-$0.08604-88.68% Bahamas
NRC Health
NRC
C$0.42-154.72%๐Ÿ‡บ๐Ÿ‡ธ USA